An interventional study of interval training exercise in Arterial Stiffness, sponsored by Cairo University. Completed at 1 site in Egypt. Open to female participants aged 40 Years to 60 Years. Per ClinicalTrials.gov, last updated 2022-03-15.
Sponsored by Cairo University · Not applicable, Interventional, and Treatment
this study is aiming to assess the chronic effect of the interval training program on arterial stiffness in women with hypertension
Cairo University is the lead sponsor of 4,911 studies on the registry; 1,443 are open to participants now.
Of its 37 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Aerobic interval training. It consisted of a modified interval cycle ergometer training program (3 days a week for 8 weeks). AIT consisted of 8 min warm up, followed by four times of 4-min intervals with HR at 80% of submaximal predetermined HR, with active phases of 3 min of cycling at 60% of submaximal predetermined HR. The exercise session was terminated by 5 min cool down
Other: interval training exercise
hypertensive medication
interval training exercise
Central arterial stiffness measurements (Pulse Wave Velocity [PWV], augmentation index )
Pulse wave analysis (PWA) of the women in the two groups: pre and post treatment for pulse wave velocity (PWV) and augmentation index(AIx) Pulse Wave Velocity \[PWV\], augmentation index (AIx @75HR) and resting heart rate were measured using analysis equipment which called Non-invasive blood pressure measurement system using "Mobil-O-Graph 24h PWA " with Hypertension Management Software Client Server (HMS-CS 4.3). PWA was performed using an oscillometric Mobil-O-Graph R 24 h PWA Monitor device (I.E.M GmbH, Germany) with integrated ARCSolver® software
Time frame: two months
blood lipid profile
blood analysis will be used to measure lipid profile (high and low-density lipoprotein, cholesterol, triglyceride)
Time frame: two months
interleukin 6
blood analysis will be used to measure interleukin 6
Time frame: two months
blood pressure (systolic and diastolic)
resting Blood pressure was monitored from the right arm using an automated digital electronic BP monitor (Omron digital BP monitor, Model 11 EM 403c; Tokyo Japan).
Time frame: two months
Ran from Jan 2021 to primary completion in Mar 2021, 2 months.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Mar 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.